Comparison of Dopamine and Norepinephrine Use for the Treatment of Hypotension in Out-Of-Hospital Cardiac Arrest Patients with Return of Spontaneous Circulation

Table 2

Association of postresuscitation inotropic agent therapy and 30-day survival and favorable neurologic performance.

	30-day survival		Favorable neurologic performance
	aOR	95% C.I.	aOR	95% C.I.
Age	0.96	0.942∼0.972	0.95	0.929∼0.974
Male	1.0	0.65∼1.67	1.8	0.84∼3.90
Charlson comorbidity index	1.0	0.91∼1.12	1.0	0.87∼1.20
Shockable rhythm	2.1	1.12∼4.11	1.6	0.56∼4.35
Epinephrine	0.9	0.89∼0.99	1.0	0.88∼1.04
Sodium bicarbonate	0.95	0.912∼0.996	1.0	0.94∼1.06
Postresuscitation inotropic therapy
Dopamine	1			1
Norepinephrine	1.0	0.48∼2.06	0.8	0.28∼2.53
Dopamine + norepinephrine	0.6	0.30∼1.10	0.2	0.04∼0.78

Shockable rhythm: ventricular fibrillation and pulseless ventricular tachycardia; aOR: adjusted odds ratio; CI: confidence interval.